Usage: Renvela (sevelamer carbonate) is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) who are on dialysis.
Usage: Sevelamer carbonate tablets are indicated for controlling serum phosphorus levels in adults and children aged 6 years and older with chronic kidney disease (CKD) who are undergoing dialysis.
Winthrop U.S, a business of sanofi-aventis U.S. LLC
Usage: Sevelamer carbonate is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) undergoing dialysis.
Winthrop U.S, a business of sanofi-aventis U.S. LLC
Usage: Sevelamer hydrochloride is indicated for controlling serum phosphorus levels in patients with chronic kidney disease (CKD) undergoing dialysis. Its safety and efficacy in CKD patients not on dialysis have not been evaluated.
Usage: Sevelamer hydrochloride tablets are indicated for controlling serum phosphorus levels in patients with chronic kidney disease (CKD) who are on dialysis. Their safety and efficacy in CKD patients not undergoing dialysis have not been evaluated.